| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/ANE.12337 |
| P698 | PubMed publication ID | 25335475 |
| P2093 | author name string | M G Cotticelli | |
| R B Wilson | |||
| Y Dong | |||
| D R Lynch | |||
| J Farmer | |||
| D Foerster | |||
| A Brocht | |||
| C Strawser | |||
| K Schadt | |||
| L Seyer | |||
| N Greeley | |||
| S Gelbard | |||
| P2860 | cites work | HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model | Q27301415 |
| Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin | Q27935734 | ||
| Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia | Q28250989 | ||
| Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia | Q28593887 | ||
| Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model | Q28743986 | ||
| Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design | Q34197370 | ||
| A rapid, noninvasive immunoassay for frataxin: Utility in assessment of Friedreich ataxia | Q34376985 | ||
| Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy | Q34646029 | ||
| Friedreich's ataxia: pathology, pathogenesis, and molecular genetics | Q34708637 | ||
| Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model. | Q36026884 | ||
| Cross-sectional analysis of electrocardiograms in a large heterogeneous cohort of Friedreich ataxia subjects | Q36907766 | ||
| A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia | Q38371318 | ||
| A short 2 week dose titration regimen reduces the severity of flu-like symptoms with initial interferon gamma-1b treatment | Q40216488 | ||
| Measuring Friedreich ataxia: complementary features of examination and performance measures | Q44822898 | ||
| Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial | Q44994050 | ||
| Binaural speech processing in individuals with auditory neuropathy | Q48766086 | ||
| Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale. | Q48932314 | ||
| Erythropoietin in Friedreich ataxia: No effect on frataxin in a randomized controlled trial | Q58451539 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interferon gamma-1b | Q582356 |
| Friedreich ataxia | Q913856 | ||
| P304 | page(s) | 7-15 | |
| P577 | publication date | 2014-10-21 | |
| P1433 | published in | Acta Neurologica Scandinavica | Q4676732 |
| P1476 | title | Open-label pilot study of interferon gamma-1b in Friedreich ataxia | |
| P478 | volume | 132 |
| Q47927277 | A longitudinal study of the SF-36 version 2 in Friedreich ataxia |
| Q88751512 | Challenges ahead for trials in Friedreich's ataxia |
| Q56700247 | Emerging therapeutics for the treatment of Friedreich’s ataxia |
| Q38648895 | Emerging therapies in Friedreich's ataxia. |
| Q36010435 | Frataxin levels in peripheral tissue in Friedreich ataxia |
| Q35891311 | Friedreich Ataxia and nephrotic syndrome: a series of two patients |
| Q38730963 | Friedreich Ataxia: current status and future prospects |
| Q40128798 | GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients |
| Q59351801 | Gene expression in chronic granulomatous disease and interferon-γ receptor-deficient cells treated in vitro with interferon-γ |
| Q51595921 | Long-term treatment with thiamine as possible medical therapy for Friedreich ataxia. |
| Q28551371 | Lymphoblast Oxidative Stress Genes as Potential Biomarkers of Disease Severity and Drug Effect in Friedreich's Ataxia |
| Q38348366 | Milestones in Friedreich ataxia: more than a century and still learning |
| Q39445743 | Pharmacological therapeutics in Friedreich ataxia: the present state |
| Q64093634 | Randomized, double-blind, placebo-controlled study of interferon- 1b in Friedreich Ataxia |
| Q92257524 | Recent Advances in the Treatment of Cerebellar Disorders |
| Q63090502 | Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia |
Search more.